Pharma Block Sciences (Nanjing) (SZSE:300725) GF Score : 82/100 (As of Dec. 14, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Pharma Block Sciences (Nanjing) GF Score?

Pharma Block Sciences (Nanjing) has the GF Score of 82, which implies that the company might have Good outperformance potential.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 5/10
2. Profitability Rank : 9/10
3. Growth Rank : 9/10
4. GF Value Rank : 2/10
5. Momentum Rank : 7/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Pharma Block Sciences (Nanjing) might have Good outperformance potential.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Competitive Comparison of Pharma Block Sciences (Nanjing)'s GF Score

For the Drug Manufacturers - Specialty & Generic subindustry, Pharma Block Sciences (Nanjing)'s GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharma Block Sciences (Nanjing)'s GF Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pharma Block Sciences (Nanjing)'s GF Score distribution charts can be found below:

* The bar in red indicates where Pharma Block Sciences (Nanjing)'s GF Score falls into.

Pharma Block Sciences (Nanjing) (SZSE:300725) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score	Performance Potential and All-in-One Screener Examples ⁽¹⁾
91 - 100	Highest outperformance potential
81 - 90	Good outperformance potential
71 - 80	Likely to have average performance
51 - 70	Poor future performance potential
0 - 50	Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Pharma Block Sciences (Nanjing) GF Score Related Terms

Thank you for viewing the detailed overview of Pharma Block Sciences (Nanjing)'s GF Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Block Sciences (Nanjing) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharma Block Sciences (Nanjing) Inc (SZSE:300725) » Definitions » GF Score

Traded in Other Exchanges

N/A

Address

10 Xuefu Road, Nanjing High-tech Industrial Development Zone, Jiangsu, Nanjing, 210032, CHN, 210032

Website

http://www.pharmablock.com

Pharma Block Sciences (Nanjing) Inc is a chemistry products and services provider through the pharmaceutical research and development process. Its core business activities include pilot plant and commercial manufacturing of key intermediates and active pharmaceutical ingredient, process development, custom synthesis and building blocks.

Executives

Yang Min Min	Directors, executives
	Directors, executives
Chen La Mei	Executives
Wu Xi Han	Director
	Executives
	Directors, executives
Luo Fei	Supervisors

Pharma Block Sciences (Nanjing) Headlines

No Headlines